2020
DOI: 10.1001/jama.2020.5442
|View full text |Cite
|
Sign up to set email alerts
|

Potential Legal Liability for Withdrawing or Withholding Ventilators During COVID-19

Abstract: With an anticipated shortage of ventilators for patients with coronavirus disease 2019 (COVID-19), hospitals, physicians, and nurses may have to make an unprecedented decision: should they withdraw or withhold ventilators from some patients and use them for other patients who have a better chance of survival? It is not uncommon for care teams to decide against initiating or continuing mechanical ventilation when such treatment would not achieve a patient's goals or directives. COVID-19 presents a different cas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
73
0
9

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(88 citation statements)
references
References 6 publications
1
73
0
9
Order By: Relevance
“…Similar concerns have been previously discussed by policy makers regarding the limited availability of means to appropriately treat patients in different contexts [18].…”
Section: Ethic Concerns and Medical Liabilitysupporting
confidence: 62%
“…Similar concerns have been previously discussed by policy makers regarding the limited availability of means to appropriately treat patients in different contexts [18].…”
Section: Ethic Concerns and Medical Liabilitysupporting
confidence: 62%
“…Health care professionals experience a higher chance of exposure risk and face extreme workloads, moral dilemmas, and rapidly varying working environments but at the same time, they handle societal shifts and emotional stress experienced by patients (52)(53)(54)(55). They are at risk of lower immunity due to long working hours (36).…”
Section: Discussionmentioning
confidence: 99%
“…Since the initial identification of SARS-CoV-2 infections in Wuhan, it has been important to identify characteristics beyond China with implications in management [1,2]. Reports describing ICU patients with SARS-CoV-2 out of China are still limited [3,4]. The clinical course of adult inpatients in Wuhan has been reported [5] with a high mortality rate and a risk of death above 90% in presence of high (0.05 ng/ml) procalcitonin (PCT) plasma [5].…”
Section: Introductionmentioning
confidence: 99%